Abstract-Iron oxide nanoparticles are currently under investigation as heating agents for hyperthermic treatment of tumors. Major determinants of effective heating include the biodistribution and minimum iron oxide loading required to achieve adequate heating at practically achievable magnetic field strengths. These inter-related criteria ultimately determine the practicality of this approach to tumor treatment. Further, in our experience the currently used treatment assessment criterion for hyperthermia treatment-cumulative equivalent minutes at 43°C, CEM 43 -provides an inadequate description of the expected treatment effectiveness. Objectives: Couple numerical models to experimental measurements to study the relative heating effectiveness described by cell death predictions. Methods: FEM numerical models were applied to increase the understanding of a carefully calibrated series of experiments in mouse mammary adenocarcinoma. Results: The numerical model results indicate that minimum tumor loadings between approximately 1.3 to 1.8 mg of Fe per cm 3 of tumor tissue are required to achieve the experimentally observed temperatures in magnetic field strengths of 32 kA/m (rms) at 162 kHz. Conclusion: We show that including multiple cell death processes operating in parallel within the numerical models provides valuable perspective on the likelihood of successful treatment.Significance: We show and believe that these assessment methods are more accurate than a single assessment figure of merit based only on the comparison of thermal histories, such as the CEM method.
damage or as an adjunct for other therapies [1] [2] [3] [4] [5] [6] . Key to success in this application is obtaining adequate heat in the target tissues [6] [7] [8] [9] . It is well understood that tumor vasculature has larger inter-endothelial gaps than most normal tissues resulting in extra-vasation of the IONPs [10] , [11] . Subsequently, cells will import IONPs from the extracellular space and cluster them into intracellular endosomes with clusters ranging in size from several hundred to thousands of particles [12] .
However, owing to their small size and the overwhelming influence of local heat transfer, it is not clear that an adequate tumor load of IONP absorbing material can be accumulated to provide sufficient power absorption in practical magnetic fields in vivo [8] . In fact, clustering is usually necessary to achieve effective heating [13] . Biodistribution and practically achievable volumetric power density remain to be quantitatively studied in vivo. Over the past decade numerical models have become the standard method of assessment of nanoparticle heating in realistic geometries [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Numerical models enable substantial improved insight compared to analytical approaches [19] , [26] , [27] .
For example, a 10°C steady-state temperature increase in a single 55 nm diameter nanoparticle requires a volume power density of 5 × 10 15 (W/m 3 ), an essentially unachievable power density [13] .
Biodistribution and practically achievable volumetric power density remain to be quantitatively studied in vivo. Over the past decade numerical models have become the standard method of assessment of nanoparticle heating in realistic geometries [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Numerical models enable substantial improved insight compared to analytical approaches [19] , [26] , [27] .
Consequently, we undertook a series of in vivo experiments coupled with realistic Finite Element Method (FEM) numerical models studies to better understand the experimental results. Additionally, we intend to determine practical quantitative engineering design criteria that can be used in treatment planning and assessment. Lv et al. [14] claim to have developed such a criterion; but, in fact, have only suggested that the tumor loading should be in the range of 5-10 mg Fe/mL of tumor. In a series of in vitro studies in four different liver tumor cell lines Yamada et al. [28] suggest that tumors 10 mm in diameter require a power density of 1.7 W/g tumor (i.e. approximately 1.8 MW/m 3 ) to achieve a steady state temperature of 50°C, and less for larger size tumors. Etheridge et al. [22] studied microliter droplets of ferro-fluid and concluded that (based on heat transfer limitations) treatable tumor volumes must exceed approximately 2 mm in characteristic dimension. We seek a more comprehensive criterion to use for IONP treatment planning.
The only tissue response assessment criterion that has been applied in IONP heating to date has been the Cumulative Equivalent Minutes (CEM 43 ) criterion typically used in hyperthermia studies. CEM 43 was applied in IONP heating models by Cheng et al. [26] , Yamada et al. [28] , and Mital et al. [19] and many others with other heating modalities. Schutt and Haemmerich [16] , Soetaert et al. [24] and Reis et al. [25] used an Arrhenius kinetic model developed by He et al. [29] to describe vascular stasis in magnetic fluid hyperthermia. Incidentally, Soetaert et al. [24] have apparently used incorrect Arrhenius coefficients in their estimation of vascular stasis.
To date no investigation has directly compared thermal damage and cell death predictions to in vivo experimental results; likewise, to date, no investigation has employed Arrhenius kinetic models of cell death, nor investigated the expected response of different cell types to thermal insult in a single heating protocol. In this investigation, we apply improved Arrhenius kinetic models of cell death for four thermally unique cell types [30] to provide an estimate of the spectrum of responses that might be expected for the measured and modeled thermal histories. We will also demonstrate the inadequacy of the singlevalue CEM 43 thermal dose prediction to describe the expected responses.
It must be appreciated that the number and variety of randomizing influences and inherent uncertainties render it impossible to precisely duplicate any in vivo experiment. For example, uncertainties and randomizing influences include at least: thermo-physical properties, perfusion spatial distribution, murine physiological responses, IONP spatial distribution, and magnetic field magnitude spatial distribution vs mouse positioning. Further, Pennes' model of perfusion, [31] as is implemented in these and all of the other numerical model studies cited, is well known and thoroughly documented to be incorrect. However, more accurate models, such as those by Weinbaum et al. [32] , Baish et al. [33] , [34] , and others are intractable without substantial amounts of anatomical data, which do not exist except for a very few cases, and certainly not in this case. Some comfort is derived from the observation that the tumor vascular bed geometry is dominated by capillaries, and the Pennes model at least includes perfusion in some sense, and has been used by all of the numerical model studies cited.
II. METHODS

A. Experimental Studies
All animal experimentation was conducted under protocols approved by the Dartmouth IACUC in accordance with NIH guidelines.
Bilateral murine mammary adenocarcinoma tumors (MTG-B) were implanted in the fore shoulders of six female C3H mice (The Jackson Laboratory, Bar Harbor, ME) and allowed to develop for two weeks prior to treatment; one to be heated and the other as a the control. Resulting tumor volumes ranged from 250 to 508 mm 3 at the time of treatment. The tumors on one side were injected with BNF IONP, which are composed of Fe 3 O 4 crystals (10-20 nm in diameter) coated with a hydroxyethyl starch coating, resulting in a total average hydrodynamic radius of 110 nm (MicroMod GmBH, Rostock, Grmany). The tumors were directly injected with 7.5 mg of iron per gram of tumor. Magnetic fluid total injection volumes ranged from 77 to 156 μl. The IONP were exposed to magnetic fields between 20 and 50 kA/m (rms) at 162 kHz for heating times between 300 and 3,600 s (5 to 60 minutes). The other-side tumor was injected with an equal volume of PBS, and acted as the control tumor.
Transient intra-tumoral temperatures were recorded at 1s intervals at "shallow", "center" and "tip" locations separated by 3 mm, as sketched in Fig. 1 , with optical probes 0.56 mm in diameter (FISO Inc., Quebec, QC, Canada). The center probe was placed as close as possible to the approximate center of the irregularly shaped tumor. Additionally, rectal, skin surface and several nearby point temperatures were also recorded. The real-time skin surface temperature was recorded with a FLIR Systems (Wilsonville, OR) thermal camera.
Mice were euthanized at 0, 24 hours, or 48 hours posttreatment. The tumor and surrounding tissues were excised and fixed in 10% neutral buffered formalin, routinely processed for 4 μm sections, and stained with Hematoxylin and Eosin (H&E) and Prussian blue stains.
B. Numerical Model Studies
Three-dimensional FEM numerical models were constructed and executed in COMSOL (Comsol, Inc. Burlington MA).
1) Model Space Geometry:
The 3D model space consisted of a 2 cm wide (x-axis) by 2.5 cm long (y-axis) by 1 cm thick (z-axis) tissue space, of which the top 0.75 mm represented the skin (Fig. 2 ). Tumors were represented by 3D ellipsoids (shaded volume in the figure) based on the measured tumor dimensions for the individual experiments and covered with a 0.75 mm thick skin subdomain. The simulated tumors were generally centered at the skin surface for the smaller tumors, and above that in the models of larger tumors.
2) Thermal Model: The models assumed an equivalent volumetric heating in the volume power generation term in the Bioheat Equation, Q gen (W/m 3 ) (spatially adjusted in some cases to better match the measured transient temperatures) where: ρ t = tissue density (kg/m 3 ), c = specific heat (J/kg), k = thermal conductivity (W/m/K), Q met = metabolic heat (W/m 3 ), w = perfusion (1/s) and T = temperature (K). The thermal properties chosen are representative of the tissues listed (see Table I ).
Metabolic heat for muscle was assumed to be similar to the overall resting metabolic rate for humans, approximately 1 (kW/m 3 ) [35] . The skin was modeled at 25% of that metabolic rate, and the tumor assumed to be 30% higher than resting muscle. Perfusion values were taken from Diller et al. for skin and muscle [36] . The initial tumor perfusion, 3 × 10 −3 (1/s), was increased to as much as 7 × 10 −3 (1/s), as required to match experimental results. Two of the experiments displayed the effects of vascular shut down in the transient temperature records, and that feature was added to those models.
The bottom surface, Z min , (Fig. 2 ) was isothermal at 37°C, and the sides were thermally insulating (zero-flux). The top skin surface was a convective heat transfer boundary with convection coefficient h = 20 (W/m 2 /K), except in one case as noted. A cooling period of 600 s preceded the heating phase to establish a pre-treatment steady state homeostatic temperature field -separate steady-state solutions verified that steady state had been achieved by 600 s. The resulting skin temperature of approximately 32°C at the end of the cooling phase agreed reasonably well with the experimental measurements.
The spatial distribution and magnitude of Q gen were first adjusted somewhat until the experiment maximum transient (or steady state) temperature record from the embedded probes ( Fig. 1) was closely approximated by the numerical model result. Where necessary, the perfusion and heat transfer coefficient were then adjusted to improve match to the measurements (e.g. Fig. 8 ).
We chose not to apply Gaussian spatial distributions to the injected nanoparticles, as was suggested by Salloum et al. [37] , because the measured distributions in our histologic work did not support them.
Volumetric heating in the iron oxide nanoparticles is dominated by Neél relaxation processes in the net magnetic spin moments at 160 kHz. [38] According to the Poynting Power Theorem the volumetric power generation is determined by the imaginary part of the magnetic permeability, μ μ 0 (H/m) [13] 
where: ω = the angular frequency (r/s), and H = the (rms) vector magnetic field strength (A/m).
The Neél relaxation phenomenon appears as an opening in the B-H hysteresis loop, where B = the magnetic flux density (T). For the BNF-starch mNPs used in this study the hysteresis loop is maximally open at about 14 (kA/m) rms, where the relative μ = 6, as in Fig. 3 [13] .
The experiments were conducted at 162 kHz in a field strength of between 20 and 50 (kA/m, rms) where the relative imaginary permeability μ" varies from 5 to about 1.5 (nominally 2.5 at the geometric mean value of 32 kA/m). The maximum achievable volumetric power density in the iron oxide at 32 kA/m was approximately 9 × 10 9 (W/m 3 ). In all of the experiments, the applied magnetic field strength was kept constant; but, of course, varied spatially as described owing primarily to differences in the elevation of the mouse tumor above the single-turn coil (which had central flux concentrators), as described elsewhere [6] . The nanoparticles have average hydrodynamic diameters of 110 nm. From the nominal IONP dimensions and estimated starch coating thickness the Fe 3 O 4 was estimated to occupy between 30 and 43% of the nanoparticle volume, and only a very small fraction of the total tumor volume in each experiment.
The effective tumor loading of the injected nanoparticles cannot be determined by experimental means alone. The numerical model results were therefore used to estimate the tumor loading achieved in each of the experiments by comparing the effective Q gen required to model the temperature record with the maximum achievable heating: effective Q gen = total tumor power/measured tumor volume. Two of the experiments exhibited evidence of micro-vascular shut down. An attempt to include published vascular shut down models suggested by Brown et al. [39] and by He et al. [40] did not yield acceptable results. Thus, in those models the microvascular perfusion was shut down at the observed time in the experiment using a conditional statement in Comsol.
3) Cell Death Models: The numerical models also included four cell death process predictions based on published data by other investigators. Three of the models were determined from the same cell death assay, propidium iodide uptake in: 1) the AT1 subline of Dunning R3327 rat prostate cells [41] , 2) SN12 human renal carcinoma cells [42] , and 3) PC3 human prostate carcinoma cells, [43] . The fourth cell line was the classic Chinese Hamster Ovary (CHO) cell data from Sapareto and Dewey's 1978 experiments [44] as improved by Pearce in 2015 [30] . This process was loss of clonogenicity in those cells, which is not precisely a cell death assay. However, these experiments were the basis of the CEM 43 method, and are therefore classically important.
Propidium iodide (PI) uptake indicates cell death due to severely compromised plasma membranes, so differences among those damage process predictions are either due to differing cellular responses to thermal stress or differing plasma membrane dissolution mechanisms. The fourth CHO "cell death" process was included to indicate the relative sensitivity of the different cell lines to thermal stress. The cell death model was directly calculated from Arrhenius kinetics, as was appropriate for the AT1 and SN12 cells:
where: C(τ ) = the remaining undamaged or surviving cell fraction, τ = total experiment time (s), T = temperature (K), E a = the activation energy (J/mole), and A = the frequency factor (s −1 ) for the damage process (Table II) . The AT1 and SN12 cells are well described by Eqs. (3) alone. However, for the PC3 and CHO cells, it is necessary to add a temperature-dependent time delay to obtain acceptably accurate results. [30] The PC3 cell PI uptake data are well fit by a time delay of: where: t d = the delay time (s), and T = the temperature ( • C). The CHO cells are well fit by a time delay of [45] :
When the model heating time exceeds the required time delay calculated from (4) and (5) the PC3 and CHO Arrhenius cell death models commence.
In the numerical models a separate integrating mode was added for each cell death process and all damage process models were disabled below 43°C. A conditional function was used to: 1) initiate heating after an initial cooling phase, 2) to terminate heating and begin the after-cooling phase, 3) disable the damage process models below 43°C, and 4) to initiate the PC3 and CHO cell death processes after the delay time elapsed. The local value of the required time delay, t d , was estimated using (4) and (5) in the transient temperature field.
Direct calculation of the time delay by (4) and (5) ignores potential cumulative effects of the temperature history; however, for a linear temperature increase no error results from this simplification, while for a square-root of time temperature history the error is only about 20 seconds over a 37 to 60°C span. Thus, direct calculation is considered adequate in this model series.
The maximum temperature for which a time delay is needed is 54.5°C for the PC3 cells and 46.9°C for the CHO cells. The four cell death processes are compared at 50°C in Fig. 4 . At 50°C the required time delays are 223s for the PC3 cells and 0 for the CHO cells. Note that the PC3 damage curve crosses the SN12 curve after the time delay expires and has a rate of descent faster than the AT1 cells.
The Cumulative Equivalent Minutes at 43°C (CEM 43 ) assessment of thermal dose was derived from the CHO cell experiment studies, and is the currently-used method in hyperthermia studies [46] , [47] . It compares transient thermal histories to an equivalent exposure at 43°C. In discrete interval form it becomes:
where: R CEM is the time scaling ratio, 43°C is the reference temperature, and Δt i (min) is spent at temperature T i ( • C). For rodent studies R CEM is taken to be 0. 45 , and approximately 
III. RESULTS
Experiment heating times ranged from 300 to 3600 (s) and maximum temperatures from 39 to 57°C. Histologic section revealed the variation in the spatial distribution of IONP uptake. Numerical model volume power generation was adjusted for center amplitude and Y-axis variation in order to better represent the indicated experimental biodistribution in some of the models. In two cases the perfusion was shut down at times indicated by the experimental temperature histories.
In all of the numerical models 600 s were allowed to reach the resting steady state before heating commenced, so the initial temperatures were 32-33°C, approximating the experiment.
A. Heating for 300 s to 51.5°C
The experiment in Fig. 5 had the shortest duration in the ensemble, and achieved 51.5°C after 300 s of heating. Steady state had not been reached at the conclusion of heating (Fig. 5(a) ). The particular tumor in this experiment had ellipsiodal diameter dimensions of 11, 8.5 and 6.3 (height) mm (volume = 307 mm 3 ). Experiment CEM 43 values are: Tip = 1033, Center = 77, and Shallow = 1.5 equivalent minutes using the typical rodent time scaling factor R CEM = 0.45.
The numerical model (Fig. 5(b) ) provided a reasonable match when the tumor center was set to Q gen = 0. tumor ellipsoid. After cooling for 600 s the temperature in the tumor (34°C) was slightly higher than the surrounding skin (33.7°C) due to its slightly higher metabolic heat (Table I) .
The second phase, tumor heating, applied Q gen (y) for the heating duration, 300s, and 200 s of cooling followed. The cooling transient temperature record matched the experiment with acceptable accuracy (Fig. 5) , indicating that the assumed heat transfer parameters were reasonable.
1) Temperature Predictions:
As is the usual case, there are a few differences between the experiment and numerical model. For example, in The tip sensor final temperature, 51.6°C, is very close to the experiment value, 51.5°C, however the initial rate of temperature rise is slightly higher, so the CEM 43 value, 1,491, is larger than for the experiment, 1,033. The model -experiment tip temperature difference was a maximum of 2.8°C at 20 s of heating, and decreased to 0.1°C at 300 s.
In this experiment the gross histologic sections, Fig. 6 (parallel to the skin surface, that is, the x-y plane), show an IONP distribution weighted anteriorly, i.e. near the tip and center locations and virtually devoid in the posterior region, explaining why the volume power density was specified as described. The tumor was harvested approximately 5 min. after heating so that the IONPs could be observed before they dispersed.
2) Cell Death Predictions:
The SN12 cells are much more thermally-robust than the AT1, PC3, and CHO cells. In Fig. 7 , the cell death predictions corresponding to the experiment described in Figs. 5 and 6 and the model results (Table III) bear this out. The kinetic nature of the damage process development is also evident in the differences between AT1 and SN12 cell death at differing heating durations. In this model the PC3 cell model predicts a maximum of 88% death (Fig. 7(c) ), the same as the AT1 cells (also 88%, not shown), and the SN12 model a maximum of 11% (Fig. 7(d) ). The CHO 99% cell death region (Fig. 7(b) ) encompasses approximately 60 to 70% of the tumor volume.
B. Heating for 900 s to 51°C With Vascular Shut Down
Two of the experiments showed evidence of vascular shutdown -a rapid temperature increase in the final stages of heating. One example is shown in Fig. 8(a) , wherein the final maximum tumor temperature, 51.3°C, only occurred in the final few seconds of heating.
Based on a time scaling ratio of R CEM = 0.45 the corresponding CEM 43 values were: Tip = 1, 192, Center = 827, and Shallow = 19 equivalent minutes. In the corresponding FEM model, it was necessary to increase the tumor perfusion to 0.007 (1/s), comparable to the high end of the range for skeletal muscle, [36] to obtain the appropriate end term temperature spike after perfusion shut down. The applied uniform volume power deposition term was Q gen = 7 × 10 5 (W/m 3 ) in this model. The total applied power coupled to the 310 mm In this experiment the IONPs at the level of the section were concentrated in the lower right quadrant (Fig. 9(b) ), which correlates with the location of the dead cells ( Fig. 9(a) ), as would be expected. The tumor was harvested approximately 5 min. after heating so that the IONPs could be observed before they dispersed.
2) Cell Death Predictions: This FEM model tumor center was located 2 mm above the skin surface in this model, consequently the plots in Fig. 10 do not show surrounding skin. In Fig. 10(a) the temperature color scale spans 42 to 51°C. In Fig. 10(b) the CHO 99% cell death boundary includes the entire tumor volume. In contrast, the maximum cell death prediction for PC3 cells is 87.1% (Fig. 10(c) ), and is nearly identical to the AT1 cells (91.8%, not shown).
At 45°C the time delay for the PC3 cells is 471 s, approximately half of the heating time -that is, the PC3 cell death model likely did not commence until about the same time as vascular shut down was enforced. The maximum death probability for the SN12 cells is 10.1% (Fig. 10(d) ).
C. Heating for 600 s to 57°C
The highest temperature result in the ensemble reached a maximum measured temperature of 57.4°C in the center location ( Fig. 11(a) ). Experiment CEM 43 values are: Tip = 20,494, Center = 227,311, and Shallow = 12,688 equivalent minutes.
This numerical model did not require alterations in the uniform spatial distribution of mNPs to obtain an acceptable result (Fig. 11) ; however, the temperature-sensing catheter position was moved 0.5 mm caudally (−y axis) to simulate a slightly higher measured tip temperature as compared to the shallow location. The applied uniform volume generation in the tumor was Q gen = 1.1 (MW/m 3 ), and the surface convection coefficient, h, was reduced to 7 (W/m 2 K). The total power coupled to the 329 mm 3 tumor was 0.361 W.
1) Transient Temperature Predictions:
The transient developments are illustrated in Fig. 11 for comparison. The comparable numerical model reached 57.5°C at the center location after 600 s of heating. The center point temperature in the numerical model was within 0.5°C of the experiment values everywhere during heating, except at the beginning and end where some edge jitter is expected. The numerical model has slightly over-estimated the tip and shallow location transient temperatures, while fairly representing the center location. The total coupled power was 0.361 W.
2) Cell Death Predictions: Histologic results are summarized in Fig. 12 , arranged comparably to those in Fig. 6 . The mid-tumor tissue cross-section reveals cell death (Fig. 12(a) ) corresponding to mNP concentrations near the tumor center and in the upper right quadrant (Fig. 12(b) ). In Fig. 12(c) , the 40X (original magnification) close up taken near the upper quadrant cell death boundary illustrates the disruption in the cell bodies, the stroma, and local vasculature, as indicated by the extra vascular red blood cells. This histologic section demonstrates the sharp necrosis -viability demarcation possible with IONP heating. It also points out the need to understand the relationship of iron concentration and distribution prior to delivery of tissue heating.
The numerical model CEM 43 A center plane temperature field for the model is shown in Fig. 13(a) . Model cell death predictions show complete cell death for the AT1 cells ( Fig. 13(b) ). The 99% isosurface in this figure encloses the entire tumor volume and is open at the top because the skin is included within the AT1 isosurface. The CHO cells show a similar response (not plotted). We estimate that the AT1 (and CHO) cell death regions occupy at least 120% of the tumor volume. The cell death prediction for PC3 cells has a maximum of 99% over 80 to 90% of the tumor volume. In Fig.  13(d) The SN12 cell death prediction (same color scale) has a maximum probability of 82.6% at the tumor center. At 57°C the CHO cells are expected to have 99% death probability for τ < 0.2 s, the AT1 cells at τ = 80 s, the PC3 cells at 95 s (no time delay), and the SN12 cells at 965 s.
D. Discussion of the Results
The model conditions were adjusted so that the maximum transient temperatures matched the experiments as closely as could be achieved. FEM numerical model volume average power densities (Q gen ) were selected to provide the best match to the steady state final temperatures in order to provide an estimate of the effective power coupled to tumor tissue. The total power required to simulate the experiment was calculated by subdomain integration in the FEM model space.
1) Uncertainties in the Model Calculations: Of course, there are deviations between the two types of records owing to the multiplicity of uncertain physical properties, effects of perfusion, thermal boundary conditions, magnetic field spatial variations, and biodistribution of the IONPs. Even when injected directly into a tumor some of the ferrofluid does not penetrate into the tumor tissues (intra-cellular and extra-cellular) but is carried by perfusion (blood and lymph) to other parts of the body. See for example: Attaluri et al. [49] Consequently, the maximum deviations between the model and experiment temperatures typically occurred during early heating and post-heat cooling. The maximum temperature was chosen as the matching variable because the cell death models are hyperbolically dependent on temperature in the exponent and extremely sensitive to small temperature differences.
2) Required Model Powers: The volume power densities, Q gen , required to simulate the measured transient temperatures ranged from 0.7 to 1.1 (MW/m 3 ). In calculating the power density by (2) the effective value of the imaginary permeability includes the volume fraction, V f , of magnetic material.
where: f = frequency (162 kHz), and μ 0 = free space permeability, 1.26 × 10 −6 (Hy/m).
3) Estimates of Tumor Loading:
The results summarized in Table IV are listed in sequence of the maximum experimental temperature, the same sequence as in Table III . The values of volume fraction,V f , were determined by comparing the total numerical model power to the measured tumor volume in (7) at the nominal magnetic field strength of 32 (kA/m), where the relative μ r = 2.5. In all of the heating models the AT1 and PC3 cells show essentially the same cell death probability, despite the difference in their activation energies, 244.8 and 222.2 (kJ/mole), respectively. This is due to the effect of the time delay required for the PC3 cells -all of the heating times are long enough to reach the region of similarity between these two processes, as shown in Fig. 4 . The SN12 cells are remarkably robust against thermal stress compared to the other three cell types.
In all cases the CHO cell and CEM predictions suggest that the heat treatment was likely quite successful. However, focusing only on the most sensitive cell type gives an inappropriately optimistic picture of likely success, in our opinion. The SN12 cells were hardly affected until a high temperature (56-57°C) was sustained for 100s of seconds, and even then only 83% cell kill was predicted. The common clinical wisdom is that successful treatments should achieve a 2-log 10 decrease in viable cells, i.e. < 1% survival. At 43°C the SN12 cells would require 1.56 × 10 5 s (43.3 hours) to show such a decrease, illustrating the limitations of the CEM 43 criterion.
In 2003 He and Bischof [50] plotted ln{A} vs. E a for Arrhenius coefficients determined independently by multiple research groups over several decades and showed that they all plot very closely to a single empirical line: ln {A} = 0.38 E a (kJ/mole) − 9.36. The rates of cell death accumulation at 50°C (Fig. 4) appear not to be monotonic with respect to the activation energies, E a (Table II) , as indeed they should be according to the He-Bischof line. [50] In fact, at 50°C the rates of damage accumulation, dΩ/dt, for the AT1 and PC3 cells are virtually identical −8.04 × 10 −3 (s −1 ) and 8.22 × 10 −3 (s −1 ), respectively, whereas the He-Bischof line values would predict 5.8 × 10 −4 and 4.9 × 10 −4 , respectively. This factor of 10 discrepancy between the predictions of the He-Bischof line and published coefficients is caused by the extreme sensitivity of the damage rate prediction to small uncertainties in the relative coefficients. Both sets of coefficients from Table II plot but result in a non-monotonic progression in damage rate in practice, presumably owing to uncertainties in the experimental data.
IV. CONCLUSION
The numerical model study has significantly improved our understanding of the experiment series and identified several important underlying phenomena. The superficial locations and small size of tumors mean that surface heat transfer is a governing thermal phenomenon: Most of the experiments resulted in steady-state temperature rises in which Q gen was balanced by local heat transfer. Successful heating of superficial tumors in the size range of 5 to 10 mm in characteristic dimension to temperatures in excess of 50°C requires an effective tumor IONP loading in excess of approximately 1.25 mg Fe /cm 3 at the nominal magnetic field strength of 32 (kA/m rms), but over the range of measured magnetic field strengths this lower limit value varies from about 1 to 3 mg Fe /cm 3 . This is a significant treatment design parameter that establishes a useful treatmentplanning criterion for IONP biodistribution.
The results also reveal the differing nature of "success" as measured by thermal damage kinetics. That is, a single assessment criterion, such as CEM 43 , can be substantially misleading since it masks the differences among cell types and the relative kinetics of their responses to thermal insult. While the CEM values were quite high in the experiments, the predicted cell death success rate was substantially lower than would be expected from CEM alone for most of the cell types. Three of the four damage processes in the numerical models were chosen because they result from the same cell death assay -propidium iodide uptake. The three different cell types respond differently to the same heating history.
Realistic treatment planning should incorporate some analysis of the range of responses to be expected and the effect of varying kinetics among cell types. A more realistic picture of likely success is realized by including maximum and minimum thermal sensitivity damage/cell death processes.
